Camber Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Camber Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,300,000	Closed	-$17.7M	–	47
2022 Q4	$17.7M	Hold	1,300,000	–	–	0.61%	31
2022 Q3	$18M	Buy	1,300,000 +359,600	+38%	+$5.34M	0.55%	38
2022 Q2	$13.5M	Buy	+940,400	New	+$16.3M	0.59%	30
2018 Q3	–	Sell	-1,647,677	Closed	-$53.3M	–	30
2018 Q2	$53.3M	Buy	1,647,677 +411,317	+33%	+$11.3M	2.05%	23
2018 Q1	$27.1M	Buy	+1,236,360	New	+$29.7M	1.33%	24
2017 Q2	–	Sell	-1,750,000	Closed	-$49.5M	–	40
2017 Q1	$49.5M	Sell	1,750,000 -750,000	-30%	-$19.9M	2.01%	18
2016 Q4	$60.5M	Sell	2,500,000 -500,000	-17%	-$12.3M	3.15%	14
2016 Q3	$71.2M	Sell	3,000,000 -1,100,000	-27%	-$24.1M	3.13%	11
2016 Q2	$75.3M	Buy	+4,100,000	New	+$64M	3.64%	6

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Camber Capital Management's CSII Position: Q1 2023 in Review

Camber Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 1,300,000 shares — an estimated $17.7M sold.

Camber Capital Management first reported a position in CSII in Q2 2016 and held it in 9 quarters. The position peaked at $75.3M in Q2 2016. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Camber Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Camber Capital Management sold 1,300,000 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $17.7M.
Camber Capital Management first reported a position in Cardiovascular Systems, Inc. in Q2 2016 and held it in 9 quarters.
Camber Capital Management's Cardiovascular Systems, Inc. position peaked at $75.3M in Q2 2016.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Camber Capital Management's 13F filing for Q1 2023, filed 15 May 2023.